Effect of Use Hormonal Progestin Birth Control on Length of Use, Incidence of Menstrual Cycle Disorders in Birth Control Acceptors in Muara Enim District in 2024

Authors

Olivia Nency , Desiani Putri Utami , Desna Pramita Devi , Laila Farhan , Meyta Sari , Mona Fitri , Neti , Rosdiana Juliani , Lidia Aryani Sapitri

DOI:

10.29303/jppipa.v10i11.8932

Published:

2024-11-25

Issue:

Vol. 10 No. 11 (2024): November

Keywords:

Birth control, Hormonal progestin, Menstrual cycle disorders

Research Articles

Downloads

How to Cite

Nency, O., Utami, D. P., Devi, D. P., Farhan, L., Sari, M., Fitri, M., … Sapitri, L. A. (2024). Effect of Use Hormonal Progestin Birth Control on Length of Use, Incidence of Menstrual Cycle Disorders in Birth Control Acceptors in Muara Enim District in 2024. Jurnal Penelitian Pendidikan IPA, 10(11), 9267–9274. https://doi.org/10.29303/jppipa.v10i11.8932
Crossref
Scopus
Google Scholar
Europe PMC

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Abstract

This study aims to determine the effect of progestin hormonal contraceptive use on the duration of use and the incidence of menstrual cycle disorders among contraceptive acceptors in Muara Enim District in 2024. The method used is a correlational design with a cross-sectional approach. The population in this study consisted of all hormonal contraceptive acceptors in Muara Enim District, with a sample size of 853 people, determined using G Power software. Data analysis was conducted using the Spearman’s rho test. The statistical test results showed a p-value of 0.000 (<0.05), indicating a significant relationship between hormonal contraceptive use and menstrual cycle disorders. A correlation coefficient of 0.28 indicates a fairly strong and positive relationship. Furthermore, there is a relationship between the duration of hormonal contraceptive use and menstrual cycle disorders, with a p-value of 0.000 (<0.05) and a correlation coefficient of 0.39, suggesting a moderate and positive relationship in the same direction. These findings are expected to provide valuable information for healthcare providers to offer more accurate recommendations regarding potential menstrual cycle disorders in progestin hormonal contraceptive users, enabling patients to better understand the possible risks associated with this contraceptive method.

References

Adiesti, F., & Wari, F. E. (2020). Hubungan Kontrasepsi Hormonal Dengan Siklus Menstruasi. Jurnal Riset Kebidanan Indonesia, 4(1), 6–12. https://doi.org/10.32536/jrki.v4i1.71

Andryani, Z. Y., Alkautzar, A. M. ah, Alza, N., Taherong, F., Firdayanti, Diarfah, A. D., Liantanty, F., Nontji, W., & Arifuddin, S. (2021). The relation of estradiol conditions and usage length to sexual dysfunction in progesterone acetate medroxepo acceptories at Bara-Baraya public health center of Makassar. Gaceta Sanitaria, 35, S475–S478. https://doi.org/10.1016/j.gaceta.2021.10.075

Armean Wright, A., Fayad, G. N., Selgrade, J. F., & Olufsen, M. S. (2020). Mechanistic model of hormonal contraception. PLoS Computational Biology, 16(6), 1–23. https://doi.org/10.1371/journal.pcbi.1007848

Azenkot, T., & Schwarz, E. B. (2022). Special Considerations for Women of Reproductive Age on Anticoagulation. Journal of General Internal Medicine, 37(11), 2803–2810. https://doi.org/10.1007/s11606-022-07528-y

Baziad, A. (2008). Kontrasepsi Hormonal. Jakarta: PT Bina Pustaka.

Beltz, A. M., Loviska, A. M., Kelly, D. P., & Nielson, M. G. (2022). The Link Between Masculinity and Spatial Skills Is Moderated by the Estrogenic and Progestational Activity of Oral Contraceptives. Frontiers in Behavioral Neuroscience, 15(January), 1–12. https://doi.org/10.3389/fnbeh.2021.777911

BKKBN. (2024). Peraturan Badan Kependudukan dan Keluarga Berencana Nasional Nomor 1 Tahun 2024. BKKBN RI. Retrieved from https://peraturan.bpk.go.id/Details/282164/perka-bkkbn-no-1-tahun-2024

Conte, F., van Buuringen, N., Voermans, N. C., & Lefeber, D. J. (2021). Galactose in human metabolism, glycosylation and congenital metabolic diseases: Time for a closer look. Biochimica et Biophysica Acta - General Subjects, 1865(8), 129898. https://doi.org/10.1016/j.bbagen.2021.129898

Contini, C., Winkler, B. S., Maass, N., Alkatout, I., Winkler, K., & Pecks, U. (2019). Concomitant intrauterine growth restriction alters the lipoprotein profile in preeclampsia. Pregnancy Hypertension, 15(October 2018), 154–160. https://doi.org/10.1016/j.preghy.2018.12.006

Edelman, A., Hemon, A., Creinin, M., Borensztein, P., Scherrer, B., & Glasier, A. (2021). Assessing the pregnancy protective impact of scheduled nonadherence to a novel progestin-only pill: Protocol for a prospective, multicenter, randomized, crossover study. JMIR Research Protocols, 10(6). https://doi.org/10.2196/29208

Elliott-Sale, K. J., McNulty, K. L., Ansdell, P., Goodall, S., Hicks, K. M., Thomas, K., Swinton, P. A., & Dolan, E. (2020). The Effects of Oral Contraceptives on Exercise Performance in Women: A Systematic Review and Meta-analysis. Sports Medicine, 50(10), 1785–1812. https://doi.org/10.1007/s40279-020-01317-5

Engseth, T. P., Andersson, E. P., Solli, G. S., Morseth, B., Thomassen, T. O., Noordhof, D. A., Sandbakk, Ø., & Welde, B. (2022). Prevalence and Self-Perceived Experiences With the Use of Hormonal Contraceptives Among Competitive Female Cross-Country Skiers and Biathletes in Norway: The FENDURA Project. Frontiers in Sports and Active Living, 4(April), 1–10. https://doi.org/10.3389/fspor.2022.873222

Fiore, M., Sentilhes, L., & d’Oiron, R. (2022). How I manage pregnancy in women with Glanzmann thrombasthenia. Blood, 139(17), 2632–2641. https://doi.org/10.1182/blood.2021011595

Ghorbanizamani, F., Moulahoum, H., Zihnioglu, F., & Timur, S. (2024). Molecularly imprinted polymers-based biosensors for gynecological diagnostics and monitoring. Talanta Open, 10(August), 100364. https://doi.org/10.1016/j.talo.2024.100364

Gurvich, C., Warren, A. M., Worsley, R., Hudaib, A. R., Thomas, N., & Kulkarni, J. (2020). Effects of oral contraceptive androgenicity on visuospatial and social-emotional cognition: A prospective observational trial. Brain Sciences, 10(4). https://doi.org/10.3390/brainsci10040194

Hampson, E., Morley, E. E., Evans, K. L., & Fleury, C. (2022). Effects of oral contraceptives on spatial cognition depend on pharmacological properties and phase of the contraceptive cycle. Frontiers in Endocrinology, 13(September), 1–19. https://doi.org/10.3389/fendo.2022.888510

Kemenkes, R. I. (2021). Pedoman Pelayanan Kontrasepsi dan Keluarga Berencana. Jakarta: Direktorat Kesehatan Keluarga, Kementerian Kesehatan Republik Indonesia.

Knoedler, J. R., Inoue, S., Bayless, D. W., Yang, T., Tantry, A., Davis, C. ha, Leung, N. Y., Parthasarathy, S., Wang, G., Alvarado, M., Rizvi, A. H., Fenno, L. E., Ramakrishnan, C., Deisseroth, K., & Shah, N. M. (2022). A functional cellular framework for sex and estrous cycle-dependent gene expression and behavior. Cell, 185(4), 654-671.e22. https://doi.org/10.1016/j.cell.2021.12.031

Laissue, P. (2015). Aetiological coding sequence variants in non-syndromic premature ovarian failure: From genetic linkage analysis to next generation sequencing. Molecular and Cellular Endocrinology, 411, 243–257. https://doi.org/10.1016/j.mce.2015.05.005

Luo, X., Jia, K., Xing, J., & Yi, J. (2024). The utilization of nanotechnology in the female reproductive system and related disorders. Heliyon, 10(3), e25477. https://doi.org/10.1016/j.heliyon.2024.e25477

Manuaba, I. B. G. (2018). Ilmu Kebidanan, Penyakit Kandungan dan Keluarga Berencana. Jakarta: EGC.

Merki-Feld, G. S., Caveng, N., Speiermann, G., & MacGregor, E. A. (2020). Migraine start, course and features over the cycle of combined hormonal contraceptive users with menstrual migraine - Temporal relation to bleeding and hormone withdrawal: A prospective diary-based study. Journal of Headache and Pain, 21(1), 1–10. https://doi.org/10.1186/s10194-020-01150-1

Nency, O., & Ramadhan, I. M. (2023). Perbandingan Pemakaian KB Hormonal Terhadap Durasi Kejadian Gangguan Siklus Haid Pada Akeptor KB Di TPMB Siti Jaojiah. Jurnal Keperawatan Muhammadiyah, 8(3). https://doi.org/10.30651/jkm.v8i3.17762

Notoatmodjo, S. (2020). Metodologi Penelitian kesehatan. Jakarta: Rineka Cipta.

Oktarina, M., Ramadhaniati, Y., Andika, P., & Melati, M. (2022). Hubungan Pengetahuan dengan Pemilihan KB Suntik Di Wilayah Kerja UPTD Puskesmas Bumi Agung Kota Pagar Alam. Ahmar Metastasis Health Journal, 1(4), 124–128. https://doi.org/10.53770/amhj.v1i4.89

Parenthood, P. (2022). The Birth Control Implant. In Planned Parenthood. Retrieved from https://www.plannedparenthood.org/learn/birth-control/birth-control-implant-nexplanon

Ratten, L. K., Plummer, E. L., Bradshaw, C. S., Fairley, C. K., Murray, G. L., Garland, S. M., Bateson, D., Tachedjian, G., Masson, L., & Vodstrcil, L. A. (2021). The Effect of Exogenous Sex Steroids on the Vaginal Microbiota: A Systematic Review. Frontiers in Cellular and Infection Microbiology, 11(November). https://doi.org/10.3389/fcimb.2021.732423

Rocca, M. L., Palumbo, A. R., Visconti, F., & Di Carlo, C. (2021). Safety and benefits of contraceptives implants: A systematic review. Pharmaceuticals, 14(6), 1–26. https://doi.org/10.3390/ph14060548

Roelens, C., Santos-Ribeiro, S., Becu, L., Mackens, S., Van Landuyt, L., Racca, A., De Vos, M., van de Vijver, A., Tournaye, H., & Blockeel, C. (2020). Frozen-warmed blastocyst transfer after 6 or 7 days of progesterone administration: impact on live birth rate in hormone replacement therapy cycles. Fertility and Sterility, 114(1), 125–132. https://doi.org/10.1016/j.fertnstert.2020.03.017

Römer, T., Bitzer, J., Egarter, C., Hadji, P., Kiechle, M., Kramer, H., Oppelt, P. G., Peters, K., Stute, P., Schaudig, K., Wiegratz, I., & Regidor, P. A. (2021). Oral Progestins in Hormonal Contraception: Importance and Future Perspectives of a New Progestin Only-Pill Containing 4 mg Drospirenone. Geburtshilfe Und Frauenheilkunde, 81(9), 1021–1030. https://doi.org/10.1055/a-1471-4408

Shaw, G. A. (2021). Mitochondria as the target for disease related hormonal dysregulation. Brain, Behavior, and Immunity - Health, 18(September), 100350. https://doi.org/10.1016/j.bbih.2021.100350

Shoupe, D. (2021). The Progestin Revolution: progestins are arising as the dominant players in the tight interlink between contraceptives and bleeding control. Contraception and Reproductive Medicine, 6(1), 1–9. https://doi.org/10.1186/s40834-020-00142-5

Sims, S. T., Ware, L., & Capodilupo, E. R. (2021). Patterns of endogenous and exogenous ovarian hormone modulation on recovery metrics across the menstrual cycle. BMJ Open Sport and Exercise Medicine, 7(3), 1–9. https://doi.org/10.1136/bmjsem-2021-001047

Sinaga, R. A. (2021). Hubungan Lama Pemakaian KB Suntik 3 bulan dengan Gangguan Mentruasi di BPS D Purba Desa Gersang. Jurnal Ilmu Kesehatan, 13(1), 13–24. https://doi.org/10.37012/jik.v13i1.460

Sisilvia, S., Nadya, E., & Khotimah, S. (2022). Hubungan lama pemakaian kb suntik 3 bulan dengan gangguan menstruasi di wilayah kerja puskesmas koto baru jorong pinang gadang kabupaten dharmasraya tahun. Jurnal Kesehatan Tambusai, 3(4), 665–669. https://doi.org/10.31004/jkt.v3i4.10435

Sugiyono. (2019). Metode Penelitian Kuantitatif, Kualitatif dan R&D. Bandung: PT Alfabeta.

Sujiyatini, N., & Kurniati, A. (2019). Asuhan Ibu Nifas Askeb III. Yogyakarta: Cyrillus Publisher.

Tolstanova, G. (2022). Differentiated approach to the treatment of external genital endometriosis as prevention of recurrence. Reproductive Health of Woman, 2(2), 66–72. https://doi.org/10.30841/2708-8731.2.2022.261813

UN. (2019). Contraceptive Use by Method 2019 - Data Booklet. Retrieved from https://www.un.org/development/desa/pd/sites/www.un.org.development.desa.pd/files/files/documents/2020/Jan/un_2019_contraceptiveusebymethod_databooklet.pdf

Vannuccini, S., Clemenza, S., Rossi, M., & Petraglia, F. (2022). Hormonal treatments for endometriosis: The endocrine background. Reviews in Endocrine and Metabolic Disorders, 23(3), 333–355. https://doi.org/10.1007/s11154-021-09666-w

Visser, N., Silva, A. V., Tarvainen, I., Damdimopoulos, A., Davey, E., Roos, K., Björvang, R. D., Kallak, T. K., Lager, S., Lavogina, D., Laws, M., Piltonen, T., Salumets, A., Flaws, J. A., Öberg, M., Velthut-Meikas, A., Damdimopoulou, P., & Olovsson, M. (2024). Epidemiologically relevant phthalates affect human endometrial cells in vitro through cell specific gene expression changes related to the cytoskeleton and mitochondria. Reproductive Toxicology, 128(July). https://doi.org/10.1016/j.reprotox.2024.108660

Wardaningtyas, A. W., & Achadi, A. (2022). Determinan Kejadian Putus Pakai Kontrasepsi Suntik Pada Wanita Usia Subur Di Jawa Barat. JIM: Jurnal Ilmiah Mahasiswa Pendidikan Sejarah, 8(3), 2576–2582. https://doi.org/10.24815/jimps.v8i3.26069

Yang, J., Wang, H., Du, H., Fang, H., Han, M., Wang, Y., Xu, L., Liu, S., Yi, J., Chen, Y., Jiang, Q., & He, G. (2022). Exposure to perfluoroalkyl substances was associated with estrogen homeostasis in pregnant women. Science of the Total Environment, 805, 150360. https://doi.org/10.1016/j.scitotenv.2021.150360

Yang, Y., Zhang, D., Qin, H., Liu, S., & Yan, Q. (2019). poFUT1 promotes endometrial decidualization by enhancing the O-fucosylation of Notch1. EBioMedicine, 44, 563–573. https://doi.org/10.1016/j.ebiom.2019.05.027

Yefimenko, O. (2020). Menopause. A problem that is not out of date: Specialist comment and updated data from the National Consensus on the Management of Patients in Menopause. Reproductive Endocrinology, 5(1), 72–88. https://doi.org/10.18370/2309-4117.2020.51.72-88

Young, R. E., & Huh, D. D. (2021). Organ-on-a-chip technology for the study of the female reproductive system. Advanced Drug Delivery Reviews, 173, 461–478. https://doi.org/10.1016/j.addr.2021.03.010

Zhang, J., Yang, Y., Liu, W., Schlenk, D., & Liu, J. (2019). Glucocorticoid and mineralocorticoid receptors and corticosteroid homeostasis are potential targets for endocrine-disrupting chemicals. Environment International, 133(August), 105133. https://doi.org/10.1016/j.envint.2019.105133

Author Biographies

Olivia Nency, Sekolah Tinggi Ilmu Kesehatan Abdi Nusantara

Desiani Putri Utami, Sekolah Tinggi Ilmu Kesehatan Abdi Nusantara

Desna Pramita Devi, Sekolah Tinggi Ilmu Kesehatan Abdi Nusantara

Laila Farhan, Sekolah Tinggi Ilmu Kesehatan Abdi Nusantara

Meyta Sari, Sekolah Tinggi Ilmu Kesehatan Abdi Nusantara

Mona Fitri, Sekolah Tinggi Ilmu Kesehatan Abdi Nusantara

Neti, Sekolah Tinggi Ilmu Kesehatan Abdi Nusantara

Rosdiana Juliani, Sekolah Tinggi Ilmu Kesehatan Abdi Nusantara

Lidia Aryani Sapitri, Sekolah Tinggi Ilmu Kesehatan Abdi Nusantara

License

Copyright (c) 2024 Olivia Nency, Desiani Putri Utami, Desna Pramita Devi, Laila Farhan, Meyta Sari, Mona Fitri, Neti, Rosdiana Juliani, Lidia Aryani Sapitri

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with Jurnal Penelitian Pendidikan IPA, agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC-BY License). This license allows authors to use all articles, data sets, graphics, and appendices in data mining applications, search engines, web sites, blogs, and other platforms by providing an appropriate reference. The journal allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Jurnal Penelitian Pendidikan IPA.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).